Avanish Vellanki

Avanish Vellanki is a highly experienced professional in the fields of finance, strategy, and biotechnology.

He holds an MBA with a focus on Finance and Strategy from the University of Minnesota - Carlson School of Management. Additionally, he pursued MBS in Biochemistry from the same university and completed his BA in Biology at Carleton College.

Avanish Vellanki is currently serving as the Cofounder, Chairman & CEO at Rain Oncology, showcasing his leadership and entrepreneurial skills.

Prior to his current role, Avanish held the position of Senior Vice President and Chief Business Officer at Aptose Biosciences, Inc. This role allowed him to demonstrate his expertise in business development and strategy within the biotechnology industry.

His extensive career also includes experience in biotechnology investment banking with Wedbush Securities, corporate development at Proteolix, and positions at reputable firms such as Citi and Bear Stearns & Co.

Avanish Vellanki's diverse background and his leadership roles in various organizations demonstrate his strong acumen in finance, corporate strategy, and biotechnology.

With a wealth of experience and a robust educational background, Avanish Vellanki continues to make significant contributions to the fields of biotechnology and finance.